chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Carotid artery stenosis, Carotid endarterectomy, Postoperative care
Clinical narrative: Left carotid stenosis; Procedures: Left Carotid Endarterectomy . Discharged after routine postoperative care. This admission was within 6 weeks of receiving the COVID vaccine.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: 5 days after administration, patient noticed redness, warmth, itchiness, hard lump to site of vaccine
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Myalgia, Pyrexia
Clinical narrative: Patient developed fever, muscle aches, cough and fatigue, tested positive for Covid-19 on 1/17/22 and was admitted to hospital on 1/16/2022
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient developed fever, muscle aches, cough and fatigue, tested positive for Covid-19 on 1/17/22 and was admitted to hospital on 1/16/2022
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death, Resuscitation
Clinical narrative: EMS called due to pt being in cardiac arrest; CPR done with O2 supplementation; history of being positive for COVID from Hospital; pt not able to be revived, and pt died in the ED
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: 72 HOURS AFTER HER BOOSTER ADMINISTRATION, PATIENT BROKE OUT IN TO A RASH FROM HER JAWLINE TO HER BELLY. SHE DID NOT HAVE A RASH AFTER THE FIRST 2 DOSES.  SHE WENT TO URGENT CARE CLINIC BECAUSE SHE WAS AFFRAID THE REACTION WOULD GET WORSE. THEY ADMINISTERED A STEROID AND ANTIHISTAMINE AND THE RASH IMPROVED WITHIN 24 HRS
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory distress syndrome, COVID-19, Coronavirus test positive, Cough, Dyspnoea
Clinical narrative: Patient test was collected on 01/20/2022 with positive covid results.  Patient had symptoms of acute respiratory distress.  Also cough, shortness of breath and fatigue.  She  has an underlying health condition of chronic lung disease. Patient was admitted on 01/20/22 and discharged the next day: 01/21/2022
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: Patient test was collected on 01/20/2022 with positive covid results.  Patient had symptoms of acute respiratory distress.  Also cough, shortness of breath and fatigue.  She  has an underlying health condition of chronic lung disease. Patient was admitted on 01/20/22 and discharged the next day: 01/21/2022
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Febrile neutropenia, Invasive ductal breast carcinoma, Neutrophil count decreased, White blood cell count decreased
Clinical narrative: Patient with invasive ductal carcinoma of the left breast diagnosed in June who presented to the ED on 9/11 with a neutropenic fever. She was started on 2g Cefepime and admitted. negative. She was started on 2g Cefepime and admitted.  Since admission she has been afebrile and hemodynamically stable, and her white count and neutrophil count have slowly increased. Upon discharge, neutrophils 1.1, WBC 2.8. No true infectious etiology was found, and antibiotics were discontinued upon discharge after 2 fulls days. ED visit and hospital admission were within 6 weeks of receiving the COVID vaccine.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Condition aggravated, Headache, Influenza A virus test negative, Migraine
Clinical narrative: Daily constant headaches, weekly migraine, treated by steroid pack and pain relief measures.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: Daily constant headaches, weekly migraine, treated by steroid pack and pain relief measures.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Exposure during pregnancy
Clinical narrative: Normal delivery on 9/30/2021. Hospital admission was within 6 weeks of receiving the COVD vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Leukocytosis, Nausea, Vomiting
Clinical narrative: Patient came to ED with nausea, vomiting, and epigastric pain.  Patient admitted to hospital with Covid and leukocytosis.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Heart rate increased, Neck pain, Pyrexia
Clinical narrative: fever, upsetstomah, high pulse rate, neck pain
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: 2 breakthrough covid cases post-vaccination.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase, Anti-cyclic citrullinated peptide antibody, Antinuclear antibody, Arthritis, Aspartate aminotransferase
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase, Blood bilirubin, Blood creatine, Blood creatine phosphokinase, Blood lactate dehydrogenase
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood sodium, Blood thyroid stimulating hormone, Body temperature increased, C-reactive protein
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chlamydia test, Complement factor C3, Complement factor C4, Discomfort
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Episcleritis, Full blood count, Hepatitis B core antibody
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatitis B surface antibody, Hepatitis C antibody, Hepatitis C virus test, Hypoaesthesia, Inflammatory pain
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Lipase, Metabolic function test, Neisseria test, Pain
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rheumatoid factor, Sleep disorder, Troponin I, Urine analysis
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, White blood cell count
Clinical narrative: bilateral episcleritis, blurry vision, pressure sensation, facial rash, increased body temperature (99.6-100.4), bilateral hand & foot inflammatory pain (lasting 2 weeks), pain disturbed sleep, shortness of breath due to pain, chest pain, numbness in foot when walking, joint inflammation.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Echocardiogram
Clinical narrative: Pain in chest, radiating to back. Sometimes on right side and sometimes on left side. Often accompanied by low fever.   Bloodwork over time (ESR and CRP) consistently showed high values indicating Inflammation.  Eventually TRANSTHORACIC ECHO COMPLETE WITH DOPPLER tests showed fluid buildup around the heart and patient was diagnosed with pericarditis and put on the medication Colchicine.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Pain, Pericarditis, Pyrexia, Red blood cell sedimentation rate
Clinical narrative: Pain in chest, radiating to back. Sometimes on right side and sometimes on left side. Often accompanied by low fever.   Bloodwork over time (ESR and CRP) consistently showed high values indicating Inflammation.  Eventually TRANSTHORACIC ECHO COMPLETE WITH DOPPLER tests showed fluid buildup around the heart and patient was diagnosed with pericarditis and put on the medication Colchicine.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased
Clinical narrative: Pain in chest, radiating to back. Sometimes on right side and sometimes on left side. Often accompanied by low fever.   Bloodwork over time (ESR and CRP) consistently showed high values indicating Inflammation.  Eventually TRANSTHORACIC ECHO COMPLETE WITH DOPPLER tests showed fluid buildup around the heart and patient was diagnosed with pericarditis and put on the medication Colchicine.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Dyspnoea, Haemoglobin decreased, Polyuria
Clinical narrative: Patient admitted to the hospital with shortness of breath.  She received IV Lasix and admission.  She was also found to have anemia with a hemoglobin several points below the level last checked. She is feeling quite a bit better after diuresis. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site pruritus, Injection site urticaria, Pruritus, Urticaria
Clinical narrative: Patient reported  the following on a call  of 03/07/2022, that she presented hives on the whole body accompanied with itichiness form  the neck down, for four days since - 02/24/22 to 02/28/22-, also report hives accompnied with itchiness on the injection site, did not reported other symptoms as trouble to breathing, tireness or dizziness or swelling, did not took any medication, but use regular body lotion to help to calm the itchiness, neither consulted to the doctor or went to the ER. On the call of 03/07/2022 reported feeling good all and the symptoms diseapeared by then.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass
Clinical narrative: The next morning after my shot, I had a lump on my right side of my neck. It is still present today. I went to my doctor and she checked it out. She also checked me for an ear infection. She gave me medicine and it did not help the lump on my neck.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Exposure during pregnancy, Normal labour
Clinical narrative: Normal labor and delivery on 10/18/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Dizziness, Dyspnoea
Clinical narrative: I woke up and I couldn't breathe it was very difficult and I was very dizzy & very weak I also had a high fever I had no appetite so I went to urgent care & they did an EKG & was told to go to ER so I went to ER & they also did an EKG and I sat there for about 4 hrs. or more & I got so hungry I left ER & I slept pretty good that night and when I woke up the next morning I was breathing better & the next day I was advised I had been exposed to COVID so I went to the pharmacy & got tested & test was positive.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Exposure to SARS-CoV-2, Hunger, Hyperpyrexia, SARS-CoV-2 test positive
Clinical narrative: I woke up and I couldn't breathe it was very difficult and I was very dizzy & very weak I also had a high fever I had no appetite so I went to urgent care & they did an EKG & was told to go to ER so I went to ER & they also did an EKG and I sat there for about 4 hrs. or more & I got so hungry I left ER & I slept pretty good that night and when I woke up the next morning I was breathing better & the next day I was advised I had been exposed to COVID so I went to the pharmacy & got tested & test was positive.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Blood lactic acid, COVID-19, COVID-19 pneumonia, Chest X-ray
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Condition aggravated, Confusional state, Death, Dyspnoea
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Endotracheal intubation, Exposure to SARS-CoV-2, Fibrin D dimer, Haemofiltration
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Hypoxia, Intensive care, Laboratory test, Lethargy
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Livedo reticularis, Malaise, Mechanical ventilation, Mental status changes, Multiple organ dysfunction syndrome
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary sepsis, Pyrexia, Renal failure, Respiratory failure, Rhonchi
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Seizure, Septic shock, Tachycardia, Tachypnoea
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Patient presents to ED 1/22/22 for reported seizure and confusion. Patient has history of seizure disorder. Positive for COVID-19. ED Differential Diagnosis (includes but not limited to): COVID-19, severe sepsis, breakthrough seizure, postictal state, pneumonia, other infectious source. Patient was confirmed to be febrile, tachycardic, tachypneic, has dyspnea and externally audible expiratory wheezes. On auscultation scattered rhonchi bilaterally with late expiratory wheezes. IV was initiated and seizure precautions instituted, pulseox was borderline and patient was put on supplemental oxygen via Oxy-mask. Patient required 6L Oxy-mask to keep sats 90%. Patient had Tylenol, fluid bolus, severe sepsis screening. This patient met institutional criteria for acute respiratory failure. Patient did not require intubation. Following initial stabilization and resuscitation, the patient's wife confirmed patient's history of brain cancer with seizure disorder. Multiple family members with confirmed COVID-19 recently. Patient had similar symptoms but did not test. Wife witnessed a seizure today before calling the emergency line.   Patient was diagnosed with Hypoxemic respiratory failure secondary to severe sepsis secondary toCOVID-19 pneumonia complicated with seizure and mental status alteration. Patient intubated urgently in the ICU. Diagnosed with severe sepsis source pulmonic. Broad spectrum antibiotics started in the ICU Zosyn/vanco Sepsis protocol. Patient became more lethargic and lower extremities appeared mottled. Patient with progressing Multi-system organ failure with COVID, on vent with worsening renal failure and hypotension admitted with covid positive, hypoxia, septic shock (lact>4, BP OK), breakthrough seizure, tachycardia. Patient intubated 1/22/22- 1/24/22- extubated. Patient required reintubation 1/29/22. Patient requires Continuous Veno-Venous Hemofiltration- no final decision prior to consult. Family decided on extubating with compassionate care and comfort measures. Patient died 2/1/22 at 12:17
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 05/15/21 who admitted with COVID complications.  Provider discharge summary below:  "Patient came in with Acute respiratory failure secondary to COVID.  She had symptoms for 10 days already.  Procal as well as CTA was negative for a PE and secondary pneumonia.  Patient was given remdesivir as well as decadron with some improvement.  She continued to require a little oxygen with activity.  She was given vitamins as well as zinc.  The decadron increased her BS so she needed higher doses of lantus and humalog.  Patient was on lantus already.  She wasn't well controlled prior to the steroids.  Humalog was added.  She was given instructions on adjusting her Insulin at home.  The patient continued to be weak but clinically stable so was discharged home.  She has follow up with her PCP.  She should take an aspirin a day for a few weeks to decrease risk of thromboembolism  She is encouraged to do deep breathing exorcizes."
Age: 0.17
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Patient received Quadracel when he should have received Vaxelis. We did reach out to the Health Department to confirm that the patient was safe to receive this vaccine. They stated he was fine, but that he would have to return to the office to receive the two vaccines not included in the Quadracel, Hep B and Hib.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Mechanical urticaria, Pruritus, Sensitive skin, Skin burning sensation
Clinical narrative: Developed dermatographia on 1/20/22. Symptoms including intense itching/burning of skin, hives/welts all over body from scalp to face, neck, chest, arms, legs, buttocks, genitals, palms, and feet. Worsened by touch, rubbing, emotional stress, and heat. I have never experienced hives in my entire life.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Developed dermatographia on 1/20/22. Symptoms including intense itching/burning of skin, hives/welts all over body from scalp to face, neck, chest, arms, legs, buttocks, genitals, palms, and feet. Worsened by touch, rubbing, emotional stress, and heat. I have never experienced hives in my entire life.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Decreased appetite, Electrocardiogram abnormal, Electrocardiogram normal
Clinical narrative: I began to have symptoms of COVID around the 5th of February, 4 days after being discharged from the hospital. It felt like a bad cold, sore throat, runny nose, body aches, headaches. These symptoms occurred for about 8-10 days, I was managing the symptoms with over the counter ibuprofen. I lost my appetite, sense of taste and smell. Symptoms have completely gone away since. The only aftermath, I went to see my physician and they conducted an EKG that showed an irregular heartbeat. I then went to a cardiologist for another EKG showing no irregular heartbeat.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate irregular, Nasopharyngitis, Oropharyngeal pain, Pain
Clinical narrative: I began to have symptoms of COVID around the 5th of February, 4 days after being discharged from the hospital. It felt like a bad cold, sore throat, runny nose, body aches, headaches. These symptoms occurred for about 8-10 days, I was managing the symptoms with over the counter ibuprofen. I lost my appetite, sense of taste and smell. Symptoms have completely gone away since. The only aftermath, I went to see my physician and they conducted an EKG that showed an irregular heartbeat. I then went to a cardiologist for another EKG showing no irregular heartbeat.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: I began to have symptoms of COVID around the 5th of February, 4 days after being discharged from the hospital. It felt like a bad cold, sore throat, runny nose, body aches, headaches. These symptoms occurred for about 8-10 days, I was managing the symptoms with over the counter ibuprofen. I lost my appetite, sense of taste and smell. Symptoms have completely gone away since. The only aftermath, I went to see my physician and they conducted an EKG that showed an irregular heartbeat. I then went to a cardiologist for another EKG showing no irregular heartbeat.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Condition aggravated, Gastrooesophageal reflux disease, Headache, Hypoaesthesia
Clinical narrative: I had left side chest pain and reflux. Numbness down the left arm.  Midcalf numbness and purpling of my foot through my ankle and all my toes. My doctor recommended to monitor it. By the morning it improved and I still just had the reflux and minor headache.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: I had left side chest pain and reflux. Numbness down the left arm.  Midcalf numbness and purpling of my foot through my ankle and all my toes. My doctor recommended to monitor it. By the morning it improved and I still just had the reflux and minor headache.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine given after 30-day fridge life. Moderna verified vaccine still okay to administer. No negative outcome.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after 30-day fridge life. Moderna verified vaccine still okay to administer. No negative outcome.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia
Clinical narrative: Patient came to ED with shortness of breath and was admitted for Covid with hypoxia.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Condition aggravated, Dizziness, Haemoglobin decreased, Melaena
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 05/06/21 who admitted to hospital with incidental COVID positive test discovered.  Provider discharge note below:  "63 year old male with a history of EtOH cirrhosis complicated by ascites, esophageal varices, and hepatic encephalopathy who presented to Hospital on 2/7/22 with worsening dizziness and lightheadedness in the setting of multiple melenic stools. He had a known history of esophageal varices that had required banding. On this occasion, he denied any recent alcohol usage, NSAID usage, Pepto Bismol, or iron supplementation.    Initial evaluation in the ED revealed a hemoglobin of 3.7. He was quickly fluid resuscitated with, in total, 3u pRBC. He was started on Protonix, Octreotide gtt, and Rocephin for SBP prophylaxis. GI was consulted and EGD was performed on 2/9/22, which revealed grade III varices in the lower third of the esophageus. Large in size, two bands were successfully placed. Following the procedure, his diet was slowly advanced. He was eventually stable for discharge. It was recommended that patient have another EGD in 3 weeks for further monitoring of esophageal varices. He was furthermore sent home with the addition of Propranolol for secondary prophylaxis for the varices. Follow-up with GI and PCP scheduled."
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oesophageal variceal ligation, Oesophagogastroduodenoscopy abnormal, Packed red blood cell transfusion, SARS-CoV-2 test positive, Varices oesophageal
Clinical narrative: Patient with 2 Pfizer COVID vaccinations, last dose 05/06/21 who admitted to hospital with incidental COVID positive test discovered.  Provider discharge note below:  "63 year old male with a history of EtOH cirrhosis complicated by ascites, esophageal varices, and hepatic encephalopathy who presented to Hospital on 2/7/22 with worsening dizziness and lightheadedness in the setting of multiple melenic stools. He had a known history of esophageal varices that had required banding. On this occasion, he denied any recent alcohol usage, NSAID usage, Pepto Bismol, or iron supplementation.    Initial evaluation in the ED revealed a hemoglobin of 3.7. He was quickly fluid resuscitated with, in total, 3u pRBC. He was started on Protonix, Octreotide gtt, and Rocephin for SBP prophylaxis. GI was consulted and EGD was performed on 2/9/22, which revealed grade III varices in the lower third of the esophageus. Large in size, two bands were successfully placed. Following the procedure, his diet was slowly advanced. He was eventually stable for discharge. It was recommended that patient have another EGD in 3 weeks for further monitoring of esophageal varices. He was furthermore sent home with the addition of Propranolol for secondary prophylaxis for the varices. Follow-up with GI and PCP scheduled."
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Computerised tomogram, Electrocardiogram, Feeling abnormal
Clinical narrative: Woke up right side of face and arm was numb. Started feeling wobbly and we to the ER. Was dx with having a blood clot on the brain and had a stroke.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: Woke up right side of face and arm was numb. Started feeling wobbly and we to the ER. Was dx with having a blood clot on the brain and had a stroke.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood albumin decreased, Blood alkaline phosphatase increased, Blood bicarbonate decreased, Blood creatinine increased
Clinical narrative: This is a 50 year old female who presented on 1/10/22 with acute progressive shortness of breath and nonproductive cough in the setting of IDDMII, HTN, CKDIII with proteinuria, normocytic anemia, mild asthma (no PFTs).  Previously had two doses of Pfizer COVID-19 vaccine early in 2021. Tested positive for COVID on 1/10/22.  -Admitted to the ICU on contact/airborne precautions, transferred to the medical ward 1/16. -Required High Flow Nasal Canula up to 25L and 70%, titrated to 1/14 NC 7L, down to 0.5L 1/19. -Received Dexamethasone 6mg daily x 9 days today -Held Remdesivir in setting of AKI on CKD -Encouraged IS, provided on discharge -Received PRN APAP, albuterol, benzonatate and Dex-Guaifenisen -On ambulatory testing 1/19, required 0.5 L at rest and 1L with ambulation -Home O2 and pulse oximeter provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood sodium decreased, Blood urea increased, COVID-19, Chest X-ray abnormal
Clinical narrative: This is a 50 year old female who presented on 1/10/22 with acute progressive shortness of breath and nonproductive cough in the setting of IDDMII, HTN, CKDIII with proteinuria, normocytic anemia, mild asthma (no PFTs).  Previously had two doses of Pfizer COVID-19 vaccine early in 2021. Tested positive for COVID on 1/10/22.  -Admitted to the ICU on contact/airborne precautions, transferred to the medical ward 1/16. -Required High Flow Nasal Canula up to 25L and 70%, titrated to 1/14 NC 7L, down to 0.5L 1/19. -Received Dexamethasone 6mg daily x 9 days today -Held Remdesivir in setting of AKI on CKD -Encouraged IS, provided on discharge -Received PRN APAP, albuterol, benzonatate and Dex-Guaifenisen -On ambulatory testing 1/19, required 0.5 L at rest and 1L with ambulation -Home O2 and pulse oximeter provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Electrocardiogram T wave inversion, Haemoglobin decreased, Hypoxia
Clinical narrative: This is a 50 year old female who presented on 1/10/22 with acute progressive shortness of breath and nonproductive cough in the setting of IDDMII, HTN, CKDIII with proteinuria, normocytic anemia, mild asthma (no PFTs).  Previously had two doses of Pfizer COVID-19 vaccine early in 2021. Tested positive for COVID on 1/10/22.  -Admitted to the ICU on contact/airborne precautions, transferred to the medical ward 1/16. -Required High Flow Nasal Canula up to 25L and 70%, titrated to 1/14 NC 7L, down to 0.5L 1/19. -Received Dexamethasone 6mg daily x 9 days today -Held Remdesivir in setting of AKI on CKD -Encouraged IS, provided on discharge -Received PRN APAP, albuterol, benzonatate and Dex-Guaifenisen -On ambulatory testing 1/19, required 0.5 L at rest and 1L with ambulation -Home O2 and pulse oximeter provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Lung infiltration, Platelet count normal, Protein total decreased, Rales
Clinical narrative: This is a 50 year old female who presented on 1/10/22 with acute progressive shortness of breath and nonproductive cough in the setting of IDDMII, HTN, CKDIII with proteinuria, normocytic anemia, mild asthma (no PFTs).  Previously had two doses of Pfizer COVID-19 vaccine early in 2021. Tested positive for COVID on 1/10/22.  -Admitted to the ICU on contact/airborne precautions, transferred to the medical ward 1/16. -Required High Flow Nasal Canula up to 25L and 70%, titrated to 1/14 NC 7L, down to 0.5L 1/19. -Received Dexamethasone 6mg daily x 9 days today -Held Remdesivir in setting of AKI on CKD -Encouraged IS, provided on discharge -Received PRN APAP, albuterol, benzonatate and Dex-Guaifenisen -On ambulatory testing 1/19, required 0.5 L at rest and 1L with ambulation -Home O2 and pulse oximeter provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea, White blood cell count normal
Clinical narrative: This is a 50 year old female who presented on 1/10/22 with acute progressive shortness of breath and nonproductive cough in the setting of IDDMII, HTN, CKDIII with proteinuria, normocytic anemia, mild asthma (no PFTs).  Previously had two doses of Pfizer COVID-19 vaccine early in 2021. Tested positive for COVID on 1/10/22.  -Admitted to the ICU on contact/airborne precautions, transferred to the medical ward 1/16. -Required High Flow Nasal Canula up to 25L and 70%, titrated to 1/14 NC 7L, down to 0.5L 1/19. -Received Dexamethasone 6mg daily x 9 days today -Held Remdesivir in setting of AKI on CKD -Encouraged IS, provided on discharge -Received PRN APAP, albuterol, benzonatate and Dex-Guaifenisen -On ambulatory testing 1/19, required 0.5 L at rest and 1L with ambulation -Home O2 and pulse oximeter provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Loss of personal independence in daily activities, Nausea
Clinical narrative: Extreme fatigue, nausea, unable to care for dependent
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after 30-day fridge life. Moderna verified vaccine still okay to administer. No negative outcome.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: was given after 30 day fridge life-Moderna verified that this was still okay to administer. No negative outcome
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Death, Inappropriate schedule of product administration, Malaise
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred.  The individual was vaccinated with the Pfizer product on 02/17/2021 and 03/19/2021. They became symptomatic for COVID-19 disease on 01/30/2022 and tested positive for COVID-19 via antigen test on 01/31/2022 at the assisted living facility at which they were a resident. They were also admitted to hospital on 01/31/2022 and remained hospitalized until their death on 02/02/2022.  The individual had been on palliative care since October 2021 and was in overall poor health at the time of the adverse event.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred.  The individual was vaccinated with the Pfizer product on 02/17/2021 and 03/19/2021. They became symptomatic for COVID-19 disease on 01/30/2022 and tested positive for COVID-19 via antigen test on 01/31/2022 at the assisted living facility at which they were a resident. They were also admitted to hospital on 01/31/2022 and remained hospitalized until their death on 02/02/2022.  The individual had been on palliative care since October 2021 and was in overall poor health at the time of the adverse event.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Vertigo
Clinical narrative: VERTIGO AND LOSS OF BALANCE